There is also some evidence pointing out that TAMs can mediate resistance of tumor cells to chemotherapy or radiotherapy by activating STAT3 in the tumor cells, which, again, enhances the proliferation and survival of malignant cells even during treatment with various chemotherapeutics (25) (Table 1). The gene discussed is STAT3; the disease is neoplasm.